IP Library Granted Patent US 11,229,777
Granted Patent B2
US 11,229,777 · App. 17/389,894 · Granted Jan 25, 2022

System and method for plaque serration

Inventors: Peter Schneider (Honolulu, HI); Robert Giasolli (Orange, CA)
Assignee: Cagent Vascular, Inc.
A61M25/104A61B17/205A61B17/320725A61M25/1011A61M25/1027A61B2017/00004A61B2017/22061A61M2025/0096A61M2025/105A61M2025/109A61M2025/1013A61M2025/1031A61M2025/1059A61M2025/1084A61M2025/1086A61M2037/003A61M2037/0023A61M2037/0046
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,229,777
App. No.
17/389,894
Granted
Jan 25, 2022
Kind
B2
Abstract

A device and method for intravascular treatment of atherosclerotic plaque prior to balloon angioplasty which microperforates the plaque with small sharp spikes acting as serrations for forming cleavage lines or planes in the plaque. The spikes may also be used to transport medication into the plaque. The plaque preparation treatment enables subsequent angioplasty to be performed at low balloon pressures of about 4 atmospheres or less, reduces dissections, and avoids injury to the arterial wall. The subsequent angioplasty may be performed with a drug-eluting balloon (DEB) or drug-coated balloon (DCB). The pre-angioplasty perforation procedure enables more drug to be absorbed during DEB or DCB angioplasty, and makes the need for a stent less likely. Alternatively, any local incidence of plaque dissection after balloon angioplasty may be treated by applying a thin, ring-shaped tack at the dissection site only, rather than applying a stent over the overall plaque site.

Claims (41)

1. A method for treating an atherosclerotic plaque intravascularly, comprising:

providing an intravascular device for pre-angioplasty treatment comprising a first expandable balloon and a plurality of microperforators extending radially outwardly from the first expandable balloon;

positioning the intravascular device at a site in a target vessel proximate the atherosclerotic plaque in a wall of the target vessel;

expanding the first expandable balloon to place the plurality of microperforators in contact with the atherosclerotic plaque and create microperforations into the atherosclerotic plaque to form cleavage lines or planes in the atherosclerotic plaque;

continuing to expand the first expandable balloon to cut with few or no separation of the atherosclerotic plaque;

removing the intravascular device from the target vessel;

positioning a separate intravascular device for angioplasty treatment comprising a catheter and a second expandable balloon at the site; and

expanding the second expandable balloon.

2. The method of claim 1 , wherein a depth of the cleavage lines or planes extend to a media layer of the arterial wall.

3. The method of claim 1 , wherein a distance between the microperforations is equal to or greater than a depth of the microperforations.

4. The method of claim 1 , wherein a distance between the microperforations is from 0.01 mm to 2 mm.

5. The method of claim 1 , wherein a depth of the microperforations is from 0.01 mm to 0.5 mm.

6. The method of claim 1 , wherein the plurality of microperforators are arranged to form a plurality of lines that extend parallel to a longitudinal axis of the intravascular device.

7. The method of claim 1 , wherein expanding the second expandable balloon is performed at a pressure of less than 4 atmospheres.

8. The method of claim 1 , wherein the second expandable balloon comprises a drug-eluting balloon or a drug-coated balloon.

9. The method of claim 1 , wherein the first expandable balloon comprises a maximum expansion diameter equal to or less than a diameter of the target vessel.

10. A method for treating an atherosclerotic plaque intravascularly, comprising:

performing a pre-angioplasty perforation procedure by providing an intravascular device comprising a first expandable balloon and a plurality of microperforators extending radially outwardly from the balloon,

positioning the intravascular device at a site in a target vessel proximate the atherosclerotic plaque in a wall of the target vessel;

expanding the first expandable balloon to place the plurality of microperforators in contact with the atherosclerotic plaque and create microperforations into the atherosclerotic plaque to form cleavage lines or planes in the atherosclerotic plaque;

continuing to expand the first expandable balloon such that the plurality of microperforators penetrate a depth into the atherosclerotic plaque to cut with few or no separation of the atherosclerotic plaque;

removing the intravascular device from the target vessel;

performing balloon angioplasty by positioning a separate intravascular device comprising a catheter and a second expandable balloon at the site; and

expanding the second expandable balloon to bring the second expandable balloon in contact with the wall of the target vessel and further expanding the second expandable balloon to dilate the atherosclerotic plaque.

11. The method of claim 10 , wherein a depth of the cleavage lines or planes extend to a media layer of the arterial wall.

12. The method of claim 10 , wherein the first expandable balloon delivers a drug or medication.

13. The method of claim 10 , wherein the plurality of microperforators comprise a height of 0.05 mm to 1.0 mm.

14. The method of claim 10 , wherein the plurality of microperforators penetrate the atherosclerotic plaque from 0.01 mm to 0.5 mm.

15. The method of claim 10 , wherein the plurality of microperforators comprise a serrated edge.

16. The method of claim 10 , wherein the plurality of microperforators comprise multiple surfaces at varying heights.

17. The method of claim 10 , wherein the first expandable balloon expands to a maximum diameter equal to or less than a diameter of the target vessel.

18. A method for treating an atherosclerotic plaque intravascularly, comprising:

providing an intravascular device comprising a first expandable balloon and a plurality of microperforators extending radially outwardly from the balloon, the plurality of microperforators arranged to form a plurality of lines that extend parallel to a longitudinal axis of the intravascular device,

positioning the intravascular device at a site in a target vessel proximate the atherosclerotic plaque in a wall of the target vessel;

expanding the first expandable balloon to place the plurality of microperforators in contact with the atherosclerotic plaque and create microperforations into the atherosclerotic plaque to form cleavage lines or planes in the atherosclerotic plaque to cut with few or no separation of the atherosclerotic plaque, such that a distance between microperforations is equal to or greater than a height of the microperforators, wherein the distance between the microperforations is from 0.01 mm to 2 mm;

continuing to expand the first expandable balloon to allow the microperforations to reach a depth of 0.01 mm to 0.5 mm;

removing the intravascular device from the target vessel;

positioning a separate intravascular device comprising a catheter and a second expandable balloon at the site; and

expanding the second expandable balloon to bring the second expandable balloon in contact with the wall of the target vessel and continuing to expand the second expandable balloon.

19. The method of claim 18 , wherein expanding the second expandable balloon is performed at a pressure of less than 4 atmospheres.

20. The method of claim 18 , wherein the second expandable balloon delivers a drug or medication.

Assignments (4)
SECURITY INTEREST Recorded Jan 24, 2025
From: CAGENT VASCULAR, INC.
To: TRINITY CAPITAL INC., AS COLLATERAL AGENT
Reel/Frame 070005/0936 →
CHANGE OF NAME Recorded Aug 17, 2021
From: CAGENT VASCULAR, LLC
To: CAGENT VASCULAR, INC.
Reel/Frame 057303/0502 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2021
From: SCHNEIDER, PETER; GIASOLLI, ROBERT
To: INNOVASC LLC
Reel/Frame 057140/0122 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2021
From: INNOVASC LLC
To: CAGENT VASCULAR, LLC
Reel/Frame 057140/0214 →
Continuity (5)
Continuation 15276575 · Sep 26, 2016
Division 12562511 · Sep 18, 2009
Continuation In Part 12408035 · Mar 20, 2009
Provisional Application 61038477 · Mar 21, 2008
Related Publication 20210353915A1 · Nov 18, 2021
Cited By (6)
US 12,232,760 US 12,233,227 US 12,357,798 US 12,594,406 US 12,642,946 US 12,714,836